InvestorsObserver
×
News Home

Is BioCardia Inc (BCDA) Stock About to Get Hot Thursday?

Thursday, August 13, 2020 11:27 AM | InvestorsObserver Analysts

Mentioned in this article

Is BioCardia Inc (BCDA) Stock About to Get Hot Thursday?

The market has been down on BioCardia Inc (BCDA) stock recently. BCDA gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
BioCardia Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BCDA!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BCDA Stock Today?

BioCardia Inc (BCDA) stock is trading at $2.46 as of 11:24 AM on Thursday, Aug 13, an increase of $0.01, or 0.41% from the previous closing price of $2.45. Volume today is 171,464 compared to average volume of 169,805. The stock has traded between $2.25 and $2.59 so far today.

To see InvestorsObserver's Sentiment Score for BioCardia Inc click here.

More About BioCardia Inc

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App